Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe


  Hepatitis

  Free Subscription


Articles published in Dig Dis Sci

Retrieve available abstracts of 106 articles:
HTML format



Single Articles


    May 2020
  1. MCNALLY BB, Carey EJ
    Azathioprine Monotherapy Is Equivalent to Dual Therapy in Maintaining Remission in Autoimmune Hepatitis.
    Dig Dis Sci. 2020 May 20. pii: 10.1007/s10620-020-06347.
    PubMed     Abstract available


  2. DOSHI SD, Stotts MJ, Hubbard RA, Goldberg DS, et al
    The Changing Burden of Alcoholic Hepatitis: Rising Incidence and Associations with Age, Gender, Race, and Geography.
    Dig Dis Sci. 2020 May 20. pii: 10.1007/s10620-020-06346.
    PubMed     Abstract available


  3. HUYNH T, Hu KQ
    Excellent Safety and Sustained Virologic Response to Direct-Acting Antivirals Treatment in HCV-Infected Geriatric Patients: A Real-World Data.
    Dig Dis Sci. 2020 May 13. pii: 10.1007/s10620-020-06286.
    PubMed     Abstract available


  4. YUEN MF, Liu SH, Seto WK, Mak LY, et al
    Cost-Utility of All-Oral Direct-Acting Antiviral Regimens for the Treatment of Genotype 1 Chronic Hepatitis C Virus-Infected Patients in Hong Kong.
    Dig Dis Sci. 2020 May 8. pii: 10.1007/s10620-020-06281.
    PubMed     Abstract available


    April 2020
  5. OUZAN D, Larrey D, Guyader D, Remy AJ, et al
    Evolution of Hepatitis C Virus Treatment During the Era of Sofosbuvir-Based Therapies: A Real-World Experience in France.
    Dig Dis Sci. 2020 Apr 18. pii: 10.1007/s10620-020-06234.
    PubMed     Abstract available


  6. CHAUHAN A, Kumar R, Sharma S, Mahanta M, et al
    Fecal Microbiota Transplantation in Hepatitis B e Antigen-Positive Chronic Hepatitis B Patients: A Pilot Study.
    Dig Dis Sci. 2020 Apr 11. pii: 10.1007/s10620-020-06246.
    PubMed     Abstract available


  7. CAREY W
    Know When to Hold 'em, Know When to Treat 'em, Know When to Cut 'em: Why Severe Alcoholic Hepatitis Is Becoming a Surgical Disease.
    Dig Dis Sci. 2020 Apr 8. pii: 10.1007/s10620-020-06239.
    PubMed    


  8. MUKHTAR NA, Evon DM, Yim C, Lok AS, et al
    Patient Knowledge, Beliefs and Barriers to Hepatitis B Care: Results of a Multicenter, Multiethnic Patient Survey.
    Dig Dis Sci. 2020 Apr 1. pii: 10.1007/s10620-020-06224.
    PubMed     Abstract available


    March 2020
  9. ZHANG X, Ying Y, Zhou P, Liu X, et al
    A Stepwise Evaluation of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure to Optimize the Indication for Urgent Liver Transplantation.
    Dig Dis Sci. 2020 Mar 6. pii: 10.1007/s10620-020-06149.
    PubMed     Abstract available


    February 2020
  10. MELLINGER JL, Stine JG
    Early Liver Transplantation for Severe Alcoholic Hepatitis.
    Dig Dis Sci. 2020 Feb 27. pii: 10.1007/s10620-020-06159.
    PubMed     Abstract available


  11. AMJAD W, Alukal J, Doycheva I, Zhang T, et al
    A Combination of N-Acetylcysteine and Prednisone Has No Benefit Over Prednisone Alone in Severe Alcoholic Hepatitis: A Retrospective Analysis.
    Dig Dis Sci. 2020 Feb 18. pii: 10.1007/s10620-020-06142.
    PubMed     Abstract available


  12. ILUZ-FREUNDLICH D, Samad N, Miles D, Osiowy C, et al
    Spontaneous Flares of Chronic Hepatitis B Virus in Hepatitis Be Antigen Negative Carriers Who Subsequently Clear Hepatitis B Surface Antigen.
    Dig Dis Sci. 2020 Feb 7. pii: 10.1007/s10620-020-06125.
    PubMed     Abstract available


    January 2020
  13. BENITEZ TM, Fernando SM, Amini C, Saab S, et al
    Geographically Focused Collocated Hepatitis C Screening and Treatment in Los Angeles's Skid Row.
    Dig Dis Sci. 2020 Jan 24. pii: 10.1007/s10620-020-06073.
    PubMed     Abstract available


  14. YANG L, Zhang Q, Song J, Wang W, et al
    Interleukin-35 Suppresses CD8(+) T Cell Activity in Patients with Viral Hepatitis-Induced Acute-on-Chronic Liver Failure.
    Dig Dis Sci. 2020 Jan 24. pii: 10.1007/s10620-020-06077.
    PubMed     Abstract available


  15. VAN BOEMMEL-WEGMANN S, Lo Re V 3rd, Park H
    Early Treatment Uptake and Cost Burden of Hepatitis C Therapies Among Newly Diagnosed Hepatitis C Patients with a Particular Focus on HIV Coinfection.
    Dig Dis Sci. 2020 Jan 14. pii: 10.1007/s10620-019-06037.
    PubMed     Abstract available


    December 2019
  16. MAHFOUZ M, Nguyen H, Tu J, Diaz CR, et al
    Knowledge and Perceptions of Hepatitis B and Hepatocellular Carcinoma Screening Guidelines Among Trainees: A Tale of Three Centers.
    Dig Dis Sci. 2019 Dec 7. pii: 10.1007/s10620-019-05980.
    PubMed     Abstract available


    November 2019
  17. CHEN Y, Ji H, Shao J, Jia Y, et al
    Different Hepatitis C Virus Infection Statuses Show a Significant Risk of Developing Type 2 Diabetes Mellitus: A Network Meta-Analysis.
    Dig Dis Sci. 2019 Nov 23. pii: 10.1007/s10620-019-05918.
    PubMed     Abstract available


  18. HSU PY, Hsu CT, Yeh ML, Huang CF, et al
    Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C.
    Dig Dis Sci. 2019 Nov 13. pii: 10.1007/s10620-019-05938.
    PubMed     Abstract available


    October 2019
  19. HUANG R, Rao H, Yang M, Gao Y, et al
    Noninvasive Measurements Predict Liver Fibrosis Well in Hepatitis C Virus Patients After Direct-Acting Antiviral Therapy.
    Dig Dis Sci. 2019 Oct 25. pii: 10.1007/s10620-019-05886.
    PubMed     Abstract available


  20. ZHANG G, Patel K, Moghe A, Reid A, et al
    Provider Perceptions of Hepatitis C Treatment Adherence and Initiation.
    Dig Dis Sci. 2019 Oct 23. pii: 10.1007/s10620-019-05877.
    PubMed     Abstract available


    September 2019
  21. O'BEIRNE J
    Readmission Following Hospitalization for Alcoholic Hepatitis: Costly or Cost-Effective?
    Dig Dis Sci. 2019 Sep 30. pii: 10.1007/s10620-019-05854.
    PubMed    


  22. WU SF, Tseng CW, Ho YC, Chen YC, et al
    Regulatory T Cell Function Modulated After Successful Direct-Acting Antiviral Treatment for Chronic Hepatitis C Patients.
    Dig Dis Sci. 2019 Sep 26. pii: 10.1007/s10620-019-05850.
    PubMed     Abstract available


    August 2019
  23. ALI RO, Moon MS, Townsend EC, Hill K, et al
    Exploring the Link Between Platelet Numbers and Vascular Homeostasis Across Early and Late Stages of Fibrosis in Hepatitis C.
    Dig Dis Sci. 2019 Aug 12. pii: 10.1007/s10620-019-05760.
    PubMed     Abstract available


  24. BURTON MJ
    In DAA We Trust: Key Factors Essential to HCV Elimination.
    Dig Dis Sci. 2019 Aug 6. pii: 10.1007/s10620-019-05748.
    PubMed    


  25. JOSHI SS, Gao S, Castillo E, Coffin CS, et al
    Presence of Precore (C)/C Promoter Mutants in Peripheral Blood Mononuclear Cells of Chronic Hepatitis B (CHB) Carriers During Pregnancy Does Not Correlate with Increased Risk of Liver Disease in 4 Years of Follow-Up.
    Dig Dis Sci. 2019 Aug 2. pii: 10.1007/s10620-019-05745.
    PubMed     Abstract available


  26. ADEJUMO AC, Cholankeril G, Iqbal U, Yoo ER, et al
    Readmission Rates and Associated Outcomes for Alcoholic Hepatitis: A Nationwide Cohort Study.
    Dig Dis Sci. 2019 Aug 1. pii: 10.1007/s10620-019-05759.
    PubMed     Abstract available


    July 2019
  27. BLOOM PP, Mojtahed A, Bethea ED, Knooihuizen SA, et al
    Computed Tomography Findings as a Novel Predictor of Alcohol-Associated Hepatitis Outcomes.
    Dig Dis Sci. 2019 Jul 30. pii: 10.1007/s10620-019-05721.
    PubMed     Abstract available


  28. MATHUR K, Vuppalanchi V, Gelow K, Vuppalanchi R, et al
    Cannabidiol (CBD) Consumption and Perceived Impact on Extrahepatic Symptoms in Patients with Autoimmune Hepatitis.
    Dig Dis Sci. 2019 Jul 30. pii: 10.1007/s10620-019-05756.
    PubMed     Abstract available


  29. COSTENTIN CE, Sogni P, Falissard B, Barbare JC, et al
    Geographical Disparities of Outcomes of Hepatocellular Carcinoma in France: The Heavier Burden of Alcohol Compared to Hepatitis C.
    Dig Dis Sci. 2019 Jul 25. pii: 10.1007/s10620-019-05724.
    PubMed     Abstract available


  30. MAK LY, Liu SH, Yap DY, Seto WK, et al
    In Vitro and In Vivo Renoprotective Effects of Telbivudine in Chronic Hepatitis B Patients Receiving Nucleotide Analogue.
    Dig Dis Sci. 2019 Jul 6. pii: 10.1007/s10620-019-05717.
    PubMed     Abstract available


  31. GAO B, Lang S, Duan Y, Wang Y, et al
    Serum and Fecal Oxylipins in Patients with Alcohol-Related Liver Disease.
    Dig Dis Sci. 2019;64:1878-1892.
    PubMed     Abstract available


    June 2019
  32. MARTIN M, Holmes S, Sim J, Hassan M, et al
    Foregone Inclusion: Neonatal CMV Hepatitis and Cholestasis.
    Dig Dis Sci. 2019 Jun 11. pii: 10.1007/s10620-019-05691.
    PubMed    


    May 2019
  33. TU W, Gong J, Tian D, Wang Z, et al
    Hepatitis B Virus X Protein Induces SATB1 Expression Through Activation of ERK and p38MAPK Pathways to Suppress Anoikis.
    Dig Dis Sci. 2019 May 30. pii: 10.1007/s10620-019-05681.
    PubMed     Abstract available


  34. LEY D, Hayney MS, Caldera F
    Third Time's a Charm: Immunization Strategies for Hepatitis B in Immunosuppressed Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2019 May 11. pii: 10.1007/s10620-019-05662.
    PubMed    


    April 2019
  35. DING L, Gong Y, Yang Z, Zou B, et al
    Lactobacillus rhamnosus GG Ameliorates Liver Injury and Hypoxic Hepatitis in Rat Model of CLP-Induced Sepsis.
    Dig Dis Sci. 2019 Apr 30. pii: 10.1007/s10620-019-05628.
    PubMed     Abstract available


  36. ZOU WY, Choi K, Kramer JR, Yu X, et al
    Risk of Hepatocellular Cancer Recurrence in Hepatitis C Virus+ Patients Treated with Direct-Acting Antiviral Agents.
    Dig Dis Sci. 2019 Apr 30. pii: 10.1007/s10620-019-05641.
    PubMed     Abstract available


  37. VOILS CI, King HA, Thorpe CT, Blalock DV, et al
    Content Validity and Reliability of a Self-Report Measure of Medication Nonadherence in Hepatitis C Treatment.
    Dig Dis Sci. 2019 Apr 29. pii: 10.1007/s10620-019-05621.
    PubMed     Abstract available


  38. LEE HL, Jang JW, Han JW, Lee SW, et al
    Early Hepatitis B Surface Antigen Seroclearance Following Antiviral Treatment in Patients with Reactivation of Resolved Hepatitis B.
    Dig Dis Sci. 2019 Apr 13. pii: 10.1007/s10620-019-05614.
    PubMed     Abstract available


  39. PRATT PK JR, Nunes D, Long MT, Farraye FA, et al
    Improved Antibody Response to Three Additional Hepatitis B Vaccine Doses Following Primary Vaccination Failure in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2019 Apr 3. pii: 10.1007/s10620-019-05595.
    PubMed     Abstract available


    March 2019
  40. AHMAD J, Reddy KR, Tillmann HL, Hayashi PH, et al
    Importance of Hepatitis C Virus RNA Testing in Patients with Suspected Drug-Induced Liver Injury.
    Dig Dis Sci. 2019 Mar 29. pii: 10.1007/s10620-019-05591.
    PubMed     Abstract available


  41. PATEL K, Zickmund SL, Jones H, Reid A, et al
    Determinants of Hepatitis C Treatment Adherence and Treatment Completion Among Veterans in the Direct Acting Antiviral Era.
    Dig Dis Sci. 2019 Mar 22. pii: 10.1007/s10620-019-05590.
    PubMed     Abstract available


  42. FELD JJ, Krassenburg LAP
    What Comes First: Treatment of Viral Hepatitis or Liver Cancer?
    Dig Dis Sci. 2019 Mar 14. pii: 10.1007/s10620-019-05518.
    PubMed     Abstract available


  43. CHEN YH, Lu SN, Wang JH, Hung CH, et al
    Pre-S/Surface and Core Promoter/Precore Mutations in Chronic Hepatitis B Patients with Severe Acute Exacerbation.
    Dig Dis Sci. 2019 Mar 5. pii: 10.1007/s10620-019-05571.
    PubMed     Abstract available


    February 2019
  44. JIAN ZW, Wu XW, Chen ZX, Wang JC, et al
    Effect of Nucleos(t)ide Analogs on Patients with Intermediate and Advanced Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Dig Dis Sci. 2019 Feb 28. pii: 10.1007/s10620-019-05543.
    PubMed     Abstract available


  45. WU T, Konyn PG, Cattaneo AW, Saab S, et al
    New Face of Hepatitis C.
    Dig Dis Sci. 2019 Feb 13. pii: 10.1007/s10620-019-05511.
    PubMed     Abstract available


  46. KWON JH, Song MJ, Jang JW, Bae SH, et al
    Efficacy and Safety of Tenofovir Disoproxil Fumarate in Treatment-Naive Patients with Chronic Hepatitis B in Korea.
    Dig Dis Sci. 2019 Feb 6. pii: 10.1007/s10620-019-05489.
    PubMed     Abstract available


  47. PHAM C, Kuo A
    Minority Report: ENUMERATing Treatment of Chronic HBV Infection Among Asian-American Communities.
    Dig Dis Sci. 2019;64:289-291.
    PubMed    


    January 2019
  48. DAKHOUL L, Jones KR, Gawrieh S, Ghabril M, et al
    Older Age and Disease Duration Are Highly Associated with Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis.
    Dig Dis Sci. 2019 Jan 7. pii: 10.1007/s10620-018-5441.
    PubMed     Abstract available


    December 2018
  49. SHETTY A, Buch A, Saab S
    Use of Hepatitis C-Positive Liver Grafts in Hepatitis C-Negative Recipients.
    Dig Dis Sci. 2018 Dec 17. pii: 10.1007/s10620-018-5404.
    PubMed     Abstract available


  50. LIU Y, Wang W, Zou Z, Hu Z, et al
    Hepatitis C Virus Entry into Macrophages/Monocytes Mainly Depends on the Phagocytosis of Macrophages.
    Dig Dis Sci. 2018 Dec 10. pii: 10.1007/s10620-018-5401.
    PubMed     Abstract available


    November 2018
  51. CHEN LY, Fan XP, Fan YC, Zhao J, et al
    BATF Interference Blocks Th17 Cell Differentiation and Inflammatory Response in Hepatitis B Virus Transgenic Mice.
    Dig Dis Sci. 2018 Nov 29. pii: 10.1007/s10620-018-5392.
    PubMed     Abstract available


  52. DE MARIA C, Ghidotti I, Grillo F, Giannini EG, et al
    Successful DAA Treatment and Global Improvement in a Cirrhotic Patient with Concomitant HCV Infection and Autoimmune Hepatitis.
    Dig Dis Sci. 2018 Nov 1. pii: 10.1007/s10620-018-5356.
    PubMed    


    October 2018
  53. CZAJA AJ, Montano-Loza AJ
    Evolving Role of Vitamin D in Immune-Mediated Disease and Its Implications in Autoimmune Hepatitis.
    Dig Dis Sci. 2018 Oct 28. pii: 10.1007/s10620-018-5351.
    PubMed     Abstract available


  54. CHANG ML, Liaw YF
    Gender Impacts on the Disease Severity of Overt Acute Hepatitis A: Different from Overt Acute Hepatitis B.
    Dig Dis Sci. 2018 Oct 25. pii: 10.1007/s10620-018-5340.
    PubMed     Abstract available


  55. LIEW ZH, Goh GB, Hao Y, Chang PE, et al
    Comparison of Hepatocellular Carcinoma in Patients with Cryptogenic Versus Hepatitis B Etiology: A Study of 1079 Cases Over 3 Decades.
    Dig Dis Sci. 2018 Oct 16. pii: 10.1007/s10620-018-5331.
    PubMed     Abstract available


  56. AHN SH, Marcellin P, Ma X, Caruntu FA, et al
    Correction to: Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis.
    Dig Dis Sci. 2018 Oct 15. pii: 10.1007/s10620-018-5294.
    PubMed     Abstract available


  57. KHALILI M, Wong RJ
    Underserved Does Not Mean Undeserved: Unfurling the HCV Care in the Safety Net.
    Dig Dis Sci. 2018 Oct 11. pii: 10.1007/s10620-018-5316.
    PubMed    


    September 2018
  58. YANNY B, Saab S, Durazo F, Latt N, et al
    Eight-Week Hepatitis C Treatment with New Direct Acting Antivirals Has a Better Safety Profile While Being Effective in the Treatment-Naive Geriatric Population Without Liver Cirrhosis and Hepatitis C Virus-RNA < 6 Million IU/mL.
    Dig Dis Sci. 2018 Sep 27. pii: 10.1007/s10620-018-5283.
    PubMed     Abstract available


  59. LEE HM, Ahn J, Kim WR, Lim JK, et al
    A Comparison Between Community and Academic Practices in the USA in the Management of Chronic Hepatitis B Patients Receiving Entecavir: Results of the ENUMERATE Study.
    Dig Dis Sci. 2018 Sep 20. pii: 10.1007/s10620-018-5281.
    PubMed     Abstract available


  60. SHERMAN KE, Rouster SD, Kang M, Umbleja T, et al
    PNPLA3 Gene Polymorphisms in HCV/HIV-Coinfected Individuals.
    Dig Dis Sci. 2018 Sep 14. pii: 10.1007/s10620-018-5278.
    PubMed     Abstract available


  61. WARDI J, Ernst O, Lilja A, Aeed H, et al
    3-Aminobenzamide Prevents Concanavalin A-Induced Acute Hepatitis by an Anti-inflammatory and Anti-oxidative Mechanism.
    Dig Dis Sci. 2018 Sep 8. pii: 10.1007/s10620-018-5267.
    PubMed     Abstract available


    August 2018
  62. ZHANG G, Yu X, Liu P, Huang X, et al
    Efficacy of Nucleoside Analogs for Chronic Hepatitis B Virus-Related Hepatocellular Carcinoma After Curative Treatment: A Meta-Analysis.
    Dig Dis Sci. 2018 Aug 23. pii: 10.1007/s10620-018-5252.
    PubMed     Abstract available


  63. AHN SH, Marcellin P, Ma X, Caruntu FA, et al
    Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis.
    Dig Dis Sci. 2018 Aug 22. pii: 10.1007/s10620-018-5251.
    PubMed     Abstract available


  64. MARSHALL MC, Herrera JL
    Lack of Patient Compliance in Real-World Practice Negatively Affects Sustained Viral Response Rates to Direct Acting Agent Therapy for Hepatitis C.
    Dig Dis Sci. 2018 Aug 20. pii: 10.1007/s10620-018-5247.
    PubMed     Abstract available


  65. SIKAVI C, Najarian L, Saab S
    Similar Sustained Virologic Response in Real-World and Clinical Trial Studies of Hepatitis C/Human Immunodeficiency Virus Coinfection.
    Dig Dis Sci. 2018 Aug 9. pii: 10.1007/s10620-018-5215.
    PubMed     Abstract available


  66. TRAN AN, Sachdev R, Fricker ZP, Leber M, et al
    Intensive Pharmacy Care Improves Outcomes of Hepatitis C Treatment in a Vulnerable Patient Population at a Safety-Net Hospital.
    Dig Dis Sci. 2018 Aug 4. pii: 10.1007/s10620-018-5231.
    PubMed     Abstract available


    July 2018
  67. STEWART RA, MacDonald BR, Chu TC, Moore JD, et al
    Ledipasvir/Sofosbuvir Effectively Treats Hepatitis C Virus Infections in an Underserved Population.
    Dig Dis Sci. 2018 Jul 16. pii: 10.1007/s10620-018-5205.
    PubMed     Abstract available


    June 2018
  68. KIM NH, Cho YK, Kim BI, Kim HJ, et al
    Effect of Metabolic Syndrome on the Clinical Outcomes of Chronic Hepatitis B Patients with Nucleos(t)ide Analogues Treatment.
    Dig Dis Sci. 2018 Jun 12. pii: 10.1007/s10620-018-5165.
    PubMed     Abstract available


    May 2018
  69. SHEN J, Liu J, Li C, Wen T, et al
    The Impact of Tumor Differentiation on the Prognosis of HBV-Associated Solitary Hepatocellular Carcinoma Following Hepatectomy: A Propensity Score Matching Analysis.
    Dig Dis Sci. 2018 May 7. pii: 10.1007/s10620-018-5077.
    PubMed     Abstract available


    April 2018
  70. CZAJA AJ
    Under-Evaluated or Unassessed Pathogenic Pathways in Autoimmune Hepatitis and Implications for Future Management.
    Dig Dis Sci. 2018 Apr 18. pii: 10.1007/s10620-018-5072.
    PubMed     Abstract available


  71. SHAH R, Ho EY, Kramer JR, Richardson P, et al
    Hepatitis B Virus Screening and Reactivation in a National VA Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Antagonists.
    Dig Dis Sci. 2018 Apr 16. pii: 10.1007/s10620-018-5042.
    PubMed     Abstract available


    March 2018
  72. ALEXANIAN D, Birg A, Volpicelli N, Glass J, et al
    Latent Hepatitis Virus Reactivation Due to Drug Reaction: DRESSed to Kill?
    Dig Dis Sci. 2018 Mar 29. pii: 10.1007/s10620-018-5028.
    PubMed    


  73. EFE C, Taii HA, Ytting H, Aehling N, et al
    Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis.
    Dig Dis Sci. 2018 Mar 22. pii: 10.1007/s10620-018-5011.
    PubMed     Abstract available


  74. KAPLAN DE
    Cost/Benefit of Hepatitis C Treatment: It Does Not End with SVR.
    Dig Dis Sci. 2018 Mar 17. pii: 10.1007/s10620-018-5014.
    PubMed    


  75. ABDEL-MONEIM A, Aboud A, Abdel-Gabbar M, Zanaty M, et al
    Retreatment Efficacy of Sofosbuvir/Ombitasvir/Paritaprevir/Ritonavir + Ribavirin for Hepatitis C Virus Genotype 4 Patients.
    Dig Dis Sci. 2018 Mar 15. pii: 10.1007/s10620-018-5005.
    PubMed     Abstract available


  76. HU KQ, Cui W
    Persistence of Circulating Hepatitis C Virus Antigens-Specific Immune Complexes in Patients with Resolved HCV Infection.
    Dig Dis Sci. 2018 Mar 8. pii: 10.1007/s10620-018-4968.
    PubMed     Abstract available


    February 2018
  77. TANEJA S, Duseja A, De A, Mehta M, et al
    Low-Dose Sofosbuvir Is Safe and Effective in Treating Chronic Hepatitis C in Patients with Severe Renal Impairment or End-Stage Renal Disease.
    Dig Dis Sci. 2018 Feb 26. pii: 10.1007/s10620-018-4979.
    PubMed     Abstract available


  78. MAIER MM, Zhou XH, Chapko M, Leipertz SL, et al
    Hepatitis C Cure Is Associated with Decreased Healthcare Costs in Cirrhotics in Retrospective Veterans Affairs Cohort.
    Dig Dis Sci. 2018 Feb 16. pii: 10.1007/s10620-018-4956.
    PubMed     Abstract available


    January 2018
  79. BENBOW JH, Elam AD, Bossi KL, Massengill DL, et al
    Analysis of Plasma Tenascin-C in Post-HCV Cirrhosis: A Prospective Study.
    Dig Dis Sci. 2018 Jan 12. pii: 10.1007/s10620-017-4860.
    PubMed     Abstract available


  80. ABDEL-HAMEED EA, Rouster SD, Boyce CL, Zhang X, et al
    Ultra-Deep Genomic Sequencing of HCV NS5A Resistance-Associated Substitutions in HCV/HIV Coinfected Patients.
    Dig Dis Sci. 2018 Jan 12. pii: 10.1007/s10620-017-4895.
    PubMed     Abstract available


  81. DONG J, Ying J, Qiu X, Lu Y, et al
    Advanced Strategies for Eliminating the cccDNA of HBV.
    Dig Dis Sci. 2018;63:7-15.
    PubMed     Abstract available


    December 2017
  82. CAMPBELL B, Lopez A, Liu B, Bhuket T, et al
    A Pilot Program Integrating Hepatitis B Virus (HBV) Screening into an Outpatient Endoscopy Unit Improves HBV Screening Among an Ethnically Diverse Safety-Net Hospital.
    Dig Dis Sci. 2017 Dec 5. pii: 10.1007/s10620-017-4870.
    PubMed     Abstract available


  83. HOVAIDA M, Torrazza-Perez E, McCarthy D
    Liver Function Tests "Gone Viral": Acute Hepatitis of Uncertain Cause.
    Dig Dis Sci. 2017 Dec 1. pii: 10.1007/s10620-017-4849.
    PubMed    


    November 2017
  84. PRIVITERA G, Spadaro L, Marchisello S, Fede G, et al
    Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance.
    Dig Dis Sci. 2017 Nov 25. pii: 10.1007/s10620-017-4862.
    PubMed     Abstract available


  85. KWAK YE, Stein SM, Lim JK
    Practice Patterns in Hepatitis B Virus Screening Before Cancer Chemotherapy in a Major US Hospital Network.
    Dig Dis Sci. 2017 Nov 24. pii: 10.1007/s10620-017-4850.
    PubMed     Abstract available


    October 2017
  86. BOSCARINO JA, Moorman AC, Rupp LB, Zhou Y, et al
    Comparison of ICD-9 Codes for Depression and Alcohol Misuse to Survey Instruments Suggests These Codes Should Be Used with Caution.
    Dig Dis Sci. 2017;62:2704-2712.
    PubMed     Abstract available


    September 2017
  87. XING J, Spradling PR, Moorman AC, Holmberg SD, et al
    A Point System to Forecast Hepatocellular Carcinoma Risk Before and After Treatment Among Persons with Chronic Hepatitis C.
    Dig Dis Sci. 2017 Sep 30. doi: 10.1007/s10620-017-4762.
    PubMed     Abstract available


  88. PARIKH ND, Fu S, Rao H, Yang M, et al
    Risk Assessment of Hepatocellular Carcinoma in Patients with Hepatitis C in China and the USA.
    Dig Dis Sci. 2017 Sep 25. doi: 10.1007/s10620-017-4776.
    PubMed     Abstract available


  89. HOSSAIN N, Puchakayala B, Kanwar P, Verma S, et al
    Risk Factor Analysis Between Newly Screened and Established Hepatitis C in GI and Hepatology Clinics.
    Dig Dis Sci. 2017 Sep 14. doi: 10.1007/s10620-017-4754.
    PubMed     Abstract available


  90. CHAN J, Gogela N, Zheng H, Lammert S, et al
    Direct-Acting Antiviral Therapy for Chronic HCV Infection Results in Liver Stiffness Regression Over 12 Months Post-treatment.
    Dig Dis Sci. 2017 Sep 8. doi: 10.1007/s10620-017-4749.
    PubMed     Abstract available


  91. IKEDA K, Kawamura Y, Kobayashi M, Kominami Y, et al
    Direct-Acting Antivirals Decreased Tumor Recurrence After Initial Treatment of Hepatitis C Virus-Related Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Sep 7. doi: 10.1007/s10620-017-4739.
    PubMed     Abstract available


  92. PURNAK T, Efe C, Kav T, Wahlin S, et al
    Treatment Response and Outcome with Two Different Prednisolone Regimens in Autoimmune Hepatitis.
    Dig Dis Sci. 2017 Sep 4. doi: 10.1007/s10620-017-4728.
    PubMed     Abstract available


  93. DU JEONG I, Jung SW, Park BR, Lee BU, et al
    Clinical Course of Partial Virologic Response with Prolonged Tenofovir Therapy in Nuclos(t)ides-Naive Patients with Chronic Hepatitis B.
    Dig Dis Sci. 2017 Sep 4. doi: 10.1007/s10620-017-4737.
    PubMed     Abstract available


    August 2017
  94. YAYA I, Roux P, Marcellin F, Salmon-Ceron D, et al
    Unstable Housing Still a Barrier to Receiving HCV Treatment in France (ANRS CO13 HEPAVIH Cohort).
    Dig Dis Sci. 2017 Aug 5. doi: 10.1007/s10620-017-4703.
    PubMed    


    July 2017
  95. CZAJA AJ
    Global Disparities and Their Implications in the Occurrence and Outcome of Autoimmune Hepatitis.
    Dig Dis Sci. 2017 Jul 14. doi: 10.1007/s10620-017-4675.
    PubMed     Abstract available


    June 2017
  96. AFSARI A, Lee E, Shokrani B, Boortalary T, et al
    Clinical and Pathological Risk Factors Associated with Liver Fibrosis and Steatosis in African-Americans with Chronic Hepatitis C.
    Dig Dis Sci. 2017 Jun 13. doi: 10.1007/s10620-017-4626.
    PubMed     Abstract available


  97. WU E, Yang M, Rao H, Fu S, et al
    Temporal Changes in the Modes of Hepatitis C Virus Transmission in the USA and Northern China.
    Dig Dis Sci. 2017 Jun 1. doi: 10.1007/s10620-017-4619.
    PubMed     Abstract available


    May 2017
  98. ROGAL SS, McCarthy R, Reid A, Rodriguez KL, et al
    Primary Care and Hepatology Provider-Perceived Barriers to and Facilitators of Hepatitis C Treatment Candidacy and Adherence.
    Dig Dis Sci. 2017 May 18. doi: 10.1007/s10620-017-4608.
    PubMed     Abstract available


  99. LENCI I, Bosa A, Milana M, Baiocchi L, et al
    Evidence of Spontaneous Post-transplant HCV Eradication in Two Failed DAA Treatments Awaiting Liver Transplantation.
    Dig Dis Sci. 2017 May 12. doi: 10.1007/s10620-017-4594.
    PubMed    


    April 2017
  100. DEVER JB, Ducom JH, Ma A, Nguyen J, et al
    Engagement in Care of High-Risk Hepatitis C Patients with Interferon-Free Direct-Acting Antiviral Therapies.
    Dig Dis Sci. 2017 Apr 4. doi: 10.1007/s10620-017-4548.
    PubMed     Abstract available


    February 2017
  101. DURAISWAMY S, Sheffield JS, Mcintire D, Leveno K, et al
    Updated Etiology and Significance of Elevated Bilirubin During Pregnancy: Changes Parallel Shift in Demographics and Vaccination Status.
    Dig Dis Sci. 2017;62:517-525.
    PubMed     Abstract available


    January 2017
  102. DELLA-GUARDIA B, Evangelista AS, Felga GE, Marins LV, et al
    Diagnostic Accuracy of Transient Elastography for Detecting Liver Fibrosis After Liver Trannsplantation: A Specific Cut-Off Value Is Really Needed?
    Dig Dis Sci. 2017;62:264-272.
    PubMed     Abstract available


    June 2016
  103. SCLAIR SN, Carrasquillo O, Czul F, Trivella JP, et al
    Quality of Care Provided by Hepatologists to Patients with Cirrhosis at Three Parallel Health Systems.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


    April 2016
  104. LIN XJ, Lao XM, Shi M, Li SP, et al
    Changes of HBV DNA After Chemoembolization for Hepatocellular Carcinoma and the Efficacy of Antiviral Treatment.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


  105. REICH JS, Farraye FA, Wasan SK
    Preventative Care in the Patient with Inflammatory Bowel Disease: What Is New?
    Dig Dis Sci. 2016.
    PubMed     Abstract available


  106. PECTASIDES E, Miksad R, Pyatibrat S, Srivastava A, et al
    Spontaneous Regression of Hepatocellular Carcinoma with Multiple Lung Metastases: A Case Report and Review of the Literature.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: